2024 annual financial data
Keros Therapeutics 2024 Net margin
Direct answer
Net margin was -5,277.55%.
Operating income was -210.83M USD and net income was -187.35M USD.
Operating cash flow was -160.87M USD.
Get free Keros Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 3.55M USD
- Operating income
- -210.83M USD
- Net income
- -187.35M USD
- Operating cash flow
- -160.87M USD